Sue Ellen Verbrugge

Statistics

Publications

Citations

328

H-Index

Active since

2009

Affiliations

Technion – Israel Institute of Technology(Current)

Amsterdam UMC Location Vrije Universiteit Amsterdam

Center for Rheumatology

Sue Ellen Verbrugge is an author at Technion – Israel Institute of Technology specializing in pharmacology, molecular pharmacology, and bortezomib therapy.

Publications per year

2009–2015

Publications

Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis

Sue Ellen Verbrugge, Yehuda G. Assaraf, Ben A. C. Dijkmans et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 107 citations

Medicine, Pharmacology, Pharmacotherapy +11

The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells

Luigi Maddaluno, Sue Ellen Verbrugge, Chiara Martinoli et al. · The Journal of Experimental Medicine · 2009 · 95 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Effect of Noncompetitive Proteasome Inhibition on Bortezomib Resistance

Xiaoming Li, Tabitha E. Wood, Remco Sprangers et al. · JNCI Journal of the National Cancer Institute · 2010 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf et al. · Oncotarget · 2015 · 31 citations · Full text

Medicine, Oncology, Pharmacology +14

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf et al. · Experimental Hematology and Oncology · 2013 · 19 citations · Full text

Life Sciences, Hematology, Pharmacology +17

1–5 of 5